Article info
Respiratory infection
Original research
Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia
- Correspondence to Roxanne Strachan, Department of Respiratory Medicine, Sydney Children's Hospital Randwick, Randwick, NSW 2031, Australia; roxanne.strachan{at}health.nsw.gov.au
Citation
Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia
Publication history
- Received August 18, 2020
- Revised November 4, 2020
- Accepted December 4, 2020
- First published January 27, 2021.
Online issue publication
September 01, 2022
Article Versions
- Previous version (8 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.